Posts filtered by tags: Vaccine[x]


Moderna's chief medical officer says that vaccine trial results only show that they prevent people from getting severely sick — not necessarily that recipients won't still be able to transmit the virus

Lab tech Sendy Puerto processes blood samples from Moderna's coronavirus vaccine clinical trials study participants September 2, 2020 in Miami, Florida. Taimy Alvarez/AP Moderna Chief Medical Officer Tal Zaks told Axios that the public should not "over-interpret" the vaccine trial results to assume life could go back to normal after adults are vaccinated. "They do not show that they prevent you from potentially carrying this virus transiently and infecting others," Zaks told Axios.  Wh...
Tags: Science, News, US, Trends, Food And Drug Administration, Astrazeneca, Fda, Vaccine, University of Oxford, Miami Florida, Zaks, Moderna, Axios, Moncef Slaoui, Coronavirus, COVID

Moderna's chief medical officer says that vaccine trial results only show that they prevent people from getting sick — not necessarily that recipients won't still be able to transmit the virus

Lab tech Sendy Puerto processes blood samples from Moderna's coronavirus vaccine clinical trials study participants September 2, 2020 in Miami, Florida. Taimy Alvarez/AP Moderna Chief Medical Officer Tal Zaks told Axios that the public should not "over-interpret" the vaccine trial results to assume life could go back to normal after adults are vaccinated. "They do not show that they prevent you from potentially carrying this virus transiently and infecting others," Zaks told Axios.  Wh...
Tags: Science, News, US, Trends, Healthcare, Food And Drug Administration, Astrazeneca, Fda, Vaccine, University of Oxford, Miami Florida, Zaks, Moderna, Axios, Moncef Slaoui, Coronavirus

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full strength dose to follow – that one was 90% effective. Oxford’s results may not ...
Tags: Health, TC, Messenger, Medicine, Tech, Medical Research, Oxford, Vaccination, Astrazeneca, Pfizer, Vaccine, Oxford University, Biotech, Vaccines, Moderna, COVID

A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump

Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel

Facebook is reportedly planning to woo Joe Biden by rolling out new vaccine and climate change features

2020 presidential candidate Joe Biden, left, and Facebook CEO Mark Zuckerberg. Reuters/Alan Freed; Tom Williams/CQ Roll Call Facebook is building a strategy to help get on President-elect Joe Biden's good side, company sources told the Financial Times. Facebook is reportedly planning to crack down harder on COVID-19 misinformation, and is considering adding an information banner to its site encouraging users to get vaccinated. Facebook is also reportedly looking at ways to encourage users ...
Tags: Facebook, Mark Zuckerberg, Climate Change, Washington, US, Trends, Joe Biden, Britain, Nick Clegg, New York Times, Paris, Vaccine, Biden, Kamala Harris, Zuckerberg, Trump

AstraZeneca and Oxford University announced a 3rd working COVID-19 vaccine, which they say is 70% effective

Researchers said the trial of more than 20,000 volunteers showed the vaccine stopped people from developing symptoms about 70% of the time on average. Carol Smiljan/NurPhoto via Getty Images The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday. In a statement, they said the vaccine is 70% effective on average. It follows results being released for two other vaccines — developed by Pfizer and Moderna — which are 95% effective. The Oxford/As...
Tags: Europe, Japan, UK, Science, Trends, Bbc, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, European Medicines Agency, EMA, Moderna, Coronavirus, COVID-19

Coronavirus vaccine czar said Moderna will seek an emergency use authorization for its vaccine by the end of November

Moderna will seek emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine by the end of the month, the coronavirus vaccine czar said Sunday. Moderna; Samantha Lee/Business Insider Moderna, the biotech company that last week announced the results of its COVID-19 vaccine, will apply with the Food and Drug Administration for an emergency use authorization by the end of the month, Moncef Slaoui, the head of the White House Operation "Warp Speed" said Sunday. ...
Tags: Science, News, Abc, US, Trends, Healthcare, Food And Drug Administration, Fda, GlaxoSmithKline, Pfizer, Vaccine, Abc News, Moderna, Slaoui, Moncef Slaoui, Connor Perrett

Collaboration is key for equitable access

Equitable access to Covid-19 vaccines, therapies and diagnostics is a moral duty The post Collaboration is key for equitable access appeared first on The Mail & Guardian.
Tags: Opinion, Therapy, Access, Collaboration, Vaccine, Openaccess, Global Health, Diagnostic, Coronavirus, COVID-19

Russia wants to distribute its questionable coronavirus vaccine to other countries: report

Russian President Vladimir Putin Mikhail Svetlov/Getty Images Russian President Vladimir Putin wants to distribute its questionable Sputnik V coronavirus vaccine to other countries, Reuters reported Saturday. Russia first approved Sputnik V in August, but experts and health officials were skeptical the vaccine would work since it did not go through necessary phase 3 trials.  The Kremlin also kept important information relevant to the vaccine's success out of the public's eye. This included...
Tags: Health, Politics, Science, Putin, Vladimir Putin, White House, Russia, International, Trends, G20, United States, G20 Summit, Pfizer, Vaccine, Kremlin, Reuters

Treasury Secretary Steven Mnuchin flubs and says the White House is 'working on a mass distribution of the virus'

Treasury Secretary Steven Mnuchin. Erin Scott/Pool/Getty Images In what appeared to be bungled remarks, Treasury Secretary Steven Mnuchin said on Friday that the White House is working to spread the coronavirus.  "We're working on a mass distribution of the virus," Mnuchin said on CNBC's "Squawk on the Street."  Presumably, Mnuchin meant to say the White House is working toward a mass distribution of a vaccine.  But people on Twitter are heralding his flubbed remarks as a way to characteri...
Tags: Politics, News, White House, US, Trends, Treasury, Vaccine, Huffington Post, Cnbc, Treasury Department, Oliver Willis, Mnuchin, David Faber, Steven Mnuchin, Steve Mnuchin, Rob Szczerba

Morgan Stanley predicts it will take 4 to 9 months to vaccinate the rest of the US after first responders and vulnerable people

Steve Parsons-WPA Pool/Getty Images Two COVID-19 vaccines, one made by Moderna, another by Pfizer and BioNTech, announced promising results from their Phase 3 trials this week.  Moderna announced that its vaccine was 94.5% effective on Monday, and Pfizer/BioNTech announced that their vaccine was 95% effective on Wednesday.  Assuming that one or both of the vaccines receive emergency approval from the FDA, first responders and vulnerable populations will receive vaccines through March, a n...
Tags: Science, News, US, Trends, Walgreens, Food And Drug Administration, Fda, Pfizer, Vaccine, Morgan Stanley, Cvs, CVS Health, Steve Parsons, Moderna, BioNtech, COVID-19

The Real Word: How will a vaccine affect the housing market?

Watch Byron Lazine and Nicole White give a real estate agent’s perspective on industry-related topics. This week, they'll discuss how a vaccine might impact the housing market and NAR’s new ethics changes.
Tags: Video, Real Estate, Opinion, Housing Market, Service, Radio, Agent, Vaccine, Code Of Ethics, NAR, Nicole White, Brokerage, Select, Byron Lazine, The Real Word, Impact of Vaccine

How the coronavirus vaccine development compares to other shots in history

The invention of the bifurcated needle allowed more efficient vaccine delivery. Carol Smiljan/NurPhoto via Getty Images Vaccine research and development has improved massively throughout history. Nearly 200 years passed between the creation of the first successful vaccine and the eventual eradication of smallpox. The influenza virus was isolated in a lab in 1933, and the first flu vaccine wasn't licensed until 1945. Coronavirus vaccine research began just a few months after the first case ...
Tags: Japan, New York, Science, London, Australia, Cdc, Germany, Boston, Africa, US, Trends, Merck, History, Harvard, Healthcare, MMR

2 stocks to buy on the Amazon Pharmacy news

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Today in healthcare news: why Wall Street analyst thinks two of the healthcare stocks pummeled by the news of Amazon Pharmacy will explode, BI Deutschland's interview with BioNTech's CEO, and Moderna salaries revealed.   Customers can now purchase prescription medica...
Tags: Amazon, Wall Street, US, Trends, Healthcare, Pfizer, Vaccine, New Mexico, Pharmacy, Don, AmerisourceBergen, Moderna, BioNtech, Business Insider New York, BLAKE DODGE, GoodRx

Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggest

Kate Bingham, Chair of the Government's Vaccine Taskforce, after starting her Novavax trial at the Royal Free Hospital, north London on October 13, 2020. Kirsty O'Connor/PA Images via Getty Images Early trial results published in The Lancet suggest The University of Oxford and AstraZeneca's COVID-19 vaccine produces an immune response and is safe in older adults. This is important because older adults are more likely to develop severe cases of the virus, and some vaccines aren't as...
Tags: UK, Science, London, Trends, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Today programme, Pollard, Royal Free Hospital, Novavax, Andrew Pollard

Biden: Trump Stalling Transition Will Put COVID Vaccine ‘Behind By Weeks Or Months’

President-elect Joe Biden rebuked President Trump on Wednesday for standing in the way of his formal transition, especially because the sitting president’s refusal to concede will put the distribution of a COVID-19 vaccine during the Biden administration “behind by weeks or months.” During a roundtable with workers on the front lines of the COVID-19 pandemic on Wednesday, Biden particularly expressed his dismay over General Services Administration chief Emily Murphy’s refusal to sign an “ascerta...
Tags: News, Joe Biden, General Services Administration, Vaccine, Biden, Meet The Press, Abc News, Trump, GSA, Atul Gawande, Gawande, Ron Klain, Klain, Incoming White House, Summer Concepcion, Emily Murphy

Zillow CEO on how COVID-19 vaccine may impact real estate tech

Barton called the vaccine a "miracle," praising the scientists behind the effort, and noted that the industry-wide move toward digital is likely "a long-term trend."
Tags: Real Estate, Technology, Internet, Radio, Pfizer, Vaccine, Zillow, Barton, Mark Mahaney, Select, Rich Barton, Moderna, COVID-19, Media and Telecommunications Virtual Conference, RBC Capital Markets Global Technology, Technoloogy

"Vaccine," in honor of Dolly Parton's research funding

When the news broke that Dolly Parton had quietly given a million dollars to Vanderbilt University back in April to fund COVID-19 vaccine research, which was used to help develop the Modern vaccine, Gretchen McCulloch of Wired wrote new lyrics to Parton's song "Jolene." — Read the rest
Tags: Post, News, Dolly Parton, Vaccine, Parton, Vanderbilt University, Jolene, Gretchen McCulloch, Jolene Read

Device that combines air circulation with UV-C light deployed in first U.S. homes to help decrease COVID-19 transmission risk

Now that we know the virus that causes COVID-19 can be transmitted via aerosol (tiny particles in the air that can hang around for a long time), researchers and engineers globally have turned their attention to helping promote air circulation where risk exposure is high, and also to kill any active viral particles that might be in the air. One such effort is the Nanowave Air, a device created by Pittsburgh-based Dynamics, Inc. (via NEXT Pittsburgh) which uses UV-C light in a safe and contained w...
Tags: Health, TC, Articles, Tech, Ceo, Virus, United States, Ultraviolet, Vaccine, Pittsburgh, Carnegie Mellon, Air Purifier, University of Pittsburgh, Occupational Safety and Health, Dynamics Inc, Center for Vaccine Research

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a 90% effectiveness metric based on preliminary analysis of the Phase 3 trial data. This result also follows a preliminary data report from Moderna about their own Phase...
Tags: Health, TC, Medicine, Tech, Medical Research, Pfizer, Vaccine, Biotech, Vaccines, U S Food and Drug Administration FDA, EUA, Moderna, BioNtech, Coronavirus, COVID-19, COVID

Pfizer picks 4 US states to trial transporting its COVID-19 vaccine at temperatures far below freezing. It's a key test of the 'cold chain' the vaccine will rely on.

A volunteer receives an experimental vaccination for the coronavirus as part of a Pfizer clinical trial at the University of Maryland's medical school. University of Maryland Pfizer is piloting delivery options for its COVID-19 vaccine in Rhode Island, Texas, New Mexico, and Tennessee, Reuters reported Tuesday. The vaccine has to be shipped and stored at minus 94 degrees Fahrenheit, which poses major distribution challenges. Moderna's vaccine, by comparison, can be stored in a fridge. ...
Tags: Texas, US, Trends, Tennessee, Healthcare, Ubs, Pfizer, Vaccine, New Mexico, Rhode Island, Reuters, Tennessee Reuters, Moderna, Coronavirus, COVID-19, Coronavirus Vaccine

Meet Stéphane Bancel, the CEO of Moderna, a company developing a coronavirus vaccine in record time that is showing early signs of success in a preliminary study

Moderna CEO Stephane Bancel attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on Dec. 5, 2019 in New York City. Steven Ferdman/Getty Images Stéphane Bancel is the CEO of Moderna, the company that translated the genetic code of the coronavirus into a vaccine. Moderna released results on Monday that said its vaccine is 94.5% effective in preventing COVID-19; human trials began in March. It typically takes several years to develop a vaccine.  The vaccine uses messenger RNA, ...
Tags: France, White House, Massachusetts, New York City, US, Trends, Strategy, Features, Healthcare, Fda, Pfizer, Vaccine, Lincoln Center, Biotech, Donald Trump, Biotechnology

Bill Gates says the first thing he'll do after a coronavirus vaccine is hug Bono

Bill Gates and Bono in 2016. GEOFF ROBINS / Stringer Microsoft founder Bill Gates and actress Rashida Jones have a new joint podcast about big global challenges. The first episode focused on the coronavirus.  When asked about the first thing he'll do once life returns to "normal," Gates said he misses people like Bono, whose in-person energy and affection can't be replicated on Zoom. "You're going to go hug Bono, that's the first thing you're going to do," Jones summarized. "Absolutel...
Tags: Science, Podcasts, Microsoft, Bono, Trends, Bill Gates, Fda, Vaccine, Anthony Fauci, Gates, Jones, Rashida Jones, Don, Fauci, Moderna, Coronavirus

Vaccine progress means the economic damage inflicted by coronavirus will be just a fraction of losses seen in the 2008 financial crisis, BlackRock says

Kirsty O'Connor/PA Images via Getty Images New analysis from the BlackRock Investment Institute shows that the economic damage inflicted by the pandemic will be just a fraction of the losses seen following the Great Financial CrisisThe firm says encouraging recent vaccine data from Moderna and Pfizer reinforces this view. "Positive news on COVID vaccines gives us greater confidence that the economic restart can re-accelerate in 2021," said a team of BlackRock analysts in a Monday note....
Tags: Asia, Japan, China, US, Trends, Markets, Financial Crisis, Economy, Pfizer, Vaccine, Biden, US GDP, Goldman, Blackrock, Moderna, Economic Outlook

I volunteered to test the Moderna coronavirus vaccine. Here's what the experience was like — and why it's given me hope for the world.

Elle Hardy. Elle Hardy Journalist Elle Hardy is taking part in a phase-three trial of Moderna's mRNA-1273 vaccine, which just announced it's 94.5% effective against coronavirus. The federal government announced in August that it would spend $1.53 billion to buy 100 million doses of the vaccine, with an option to purchase up to 400 million additional doses. After a slight reaction to the two doses, Hardy said she was certain she didn't receive a placebo.  A recent antibody test confirmed sh...
Tags: Health, South Korea, England, Instagram, Australia, White House, US, Trends, United States, Healthcare, Oxford, MMR, Vaccine, Donald Trump, Nordic, Hardy

Moderna's promising coronavirus vaccine is a major beneficiary of the Trump administration's Operation Warp Speed

University of Miami Miller School of Medicine lab tech Sendy Puerto processes blood samples from study participants in the specimen processing lab, Wednesday, Sept. 2, 2020 in Miami. The volunteers are taking part in testing the NIH funded Moderna COVID-19 vaccine. Taimy Alvarez/AP Biotechnology firm Moderna announced promising results from clinical trials of its COVID-19 vaccine candidate on Monday, with its vaccine showing 94.5% efficacy in preventing COVID-19 infections.  Moderna is a ...
Tags: Politics, China, US, Trends, Healthcare, Astrazeneca, Miami, Fda, Pfizer, Vaccine, Oxford University, Donald Trump, Nih, Trump, Johnson Johnson, Department of Health and Human Services HHS

Azar Defends WH’s Refusal To Share COVID Vaccine Plans With Biden’s Transition Team

Secretary of Health and Human Services (HHS) Alex Azar, who heads the White House’s COVID-19 vaccine efforts, on Monday morning backed the Trump administration’s refusal to share its resources on the vaccine with President-Elect Joe Biden. When “Good Morning America” host George Stephanopoulos brought up how Biden’s transition team has been blocked from accessing information on the administration’s vaccine distribution plans, Azar pointed to the General Service Administration (GSA), whose Tru...
Tags: News, White House, Joe Biden, Vaccine, Biden, George Stephanopoulos, Trump, HHS, GSA, Stephanopoulos, Health and Human Services HHS, Ron Klain, Azar, Cristina Cabrera, Alex Azar, General Service Administration GSA

Moderna Says Its COVID Vaccine Appears To Be 95% Effective

Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide. The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna’s ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek p...
Tags: Asia, Europe, News, National Institutes of Health, Associated Press, Pfizer, Vaccine, Pfizer Inc, Cambridge Massachusetts, Hoge, Moderna, David Taintor, Associated Press Health and Science Department, COVID-19, Stephen Hoge Moderna

US stock futures rally after drugmaker Moderna touts COVID-vaccine that proved 94.5% effective in trials

Medical syringes are seen with Moderna company logo displayed on a screen in the background i Nur Photo/Getty Images Futures on the S&P 500 and the Dow Jones rise towards intraday highs, after drugmaker Moderna says its COVID-19 trial vaccine proved to be 94.5% effective. Crude oil futures rally by more than 3%, while technology stocks and gold fell and Treasury yields held steady.  Moderna said its product can be stored for a month at typical fridge temperatures, solidifying optimism that...
Tags: US, Trends, Markets, Stock Markets, Treasury, Astrazeneca, Tokyo, Pfizer, Vaccine, Goldman, Crude Oil, Futures, Johnson Johnson, BMO Capital Markets, US Treasuries, Moderna